New Study Published in PNAS Confirms Potential Utility of Marillion´s Nanoparticle Technology for Tumor Targeting Agents
Date: 5.1.2006
Marillion Pharmaceuticals, an emerging biotechnology company developing cancer therapeutics, announced that the science underlying its core technology was published in the "Proceedings of the National Academy of Sciences" (PNAS).
Marillion´s nanoplatform conjugates tumor-homing molecules to naturally occurring nanoparticles responsible for lipid transport throughout the body. The adapted nanoparticles are able to deliver anti-cancer drugs directly into tumor cells. The technology was developed by scientists from the University of Pennsylvania who helped found the company.
For more information please click "here":[ http://www.bionity.com/news/e/50552/?ps=biotechnology&pw=a&t=&defop=and&wild=yes&sdate=01/01/1995&edate=01/02/2006&sort=1].
Related articles
Nanoparticles improve delivery of medicines and diagnostics - Tiny, biodegradable particles filled with medicine may also contain answers to some of the biggest human health problems, including cancer and tuberculosis (14.4.2007)
